awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q37045504-209B47A7-A301-499C-84C6-64EBCF080CC7
Q37045504-209B47A7-A301-499C-84C6-64EBCF080CC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37045504-209B47A7-A301-499C-84C6-64EBCF080CC7
Is there a progression-free survival benefit of first-line crizotinib versus standard chemotherapy and second-line crizotinib in ALK-positive advanced lung adenocarcinoma? A retrospective study of Chinese patients.
P2860
Q37045504-209B47A7-A301-499C-84C6-64EBCF080CC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37045504-209B47A7-A301-499C-84C6-64EBCF080CC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
49014a953a7c4a5efe3785ff95a3d40733a59101
P2860
Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene.